These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6362078)

  • 1. Comparative study of the effect of ochratoxin A analogues on yeast aminoacyl-tRNA synthetases and on the growth and protein synthesis of hepatoma cells.
    Creppy EE; Kern D; Steyn PS; Vleggaar R; Röschenthaler R; Dirheimer G
    Toxicol Lett; 1983 Dec; 19(3):217-24. PubMed ID: 6362078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ochratoxin A metabolites on yeast phenylalanyl-tRNA synthetase and on the growth and in vivo protein synthesis of hepatoma cells.
    Creppy EE; Størmer FC; Kern D; Röschenthaler R; Dirheimer G
    Chem Biol Interact; 1983 Nov; 47(2):239-47. PubMed ID: 6652810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ochratoxin B on the ochratoxin A inhibition of phenylalanyl-tRNA formation in vitro and protein synthesis in hepatoma tissue culture cells.
    Roth A; Creppy EE; Kane A; Bacha H; Steyn PS; Röschenthaler R; Dirheimer G
    Toxicol Lett; 1989 Feb; 45(2-3):307-13. PubMed ID: 2919408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of ochratoxin A.
    Dirheimer G; Creppy EE
    IARC Sci Publ; 1991; (115):171-86. PubMed ID: 1820332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of yeast phenylalanyl-tRNA synthetase by ochratoxin A.
    Creppy EE; Lugnier AA; Fasiolo F; Heller K; Röschenthaler R; Dirheimer G
    Chem Biol Interact; 1979 Feb; 24(2):257-61. PubMed ID: 371840
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro inhibition of yeast valyl-tRNA synthetase by the valine homologue of ochratoxin A.
    Creppy EE; Mayer M; Kern D; Schlegel M; Steyn PS; Vleggaar R; Dirheimer G
    Biochim Biophys Acta; 1981 Dec; 656(2):265-8. PubMed ID: 6274411
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of phenylalanine tRNA synthetase from Bacillus subtilis by ochratoxin A.
    Konrad I; Röschenthaler R
    FEBS Lett; 1977 Nov; 83(2):341-7. PubMed ID: 412710
    [No Abstract]   [Full Text] [Related]  

  • 8. Action of ochratoxin A on cultured hepatoma cells--reversion of inhibition by phenylalanine.
    Creppy EE; Lugnier AA; Beck G; Röschenthaler R; Dirheimer G
    FEBS Lett; 1979 Aug; 104(2):287-90. PubMed ID: 477989
    [No Abstract]   [Full Text] [Related]  

  • 9. The myocotoxin ochratoxin A is a substrate for phenylalanine hydroxylase in isolated rat hepatocytes and in vivo.
    Creppy EE; Chakor K; Fisher MJ; Dirheimer G
    Arch Toxicol; 1990; 64(4):279-84. PubMed ID: 2167054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined action of citrinin and ochratoxin A on hepatoma tissue culture cells.
    Creppy EE; Lorkowski G; Beck G; Röschenthaler R; Dirheimer G
    Toxicol Lett; 1980 May; 5(6):375-80. PubMed ID: 7394832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation and nephrotoxicity of ochratoxin B in rats.
    Mally A; Keim-Heusler H; Amberg A; Kurz M; Zepnik H; Mantle P; Völkel W; Hard GC; Dekant W
    Toxicol Appl Pharmacol; 2005 Aug; 206(1):43-53. PubMed ID: 15963343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary aspects of accuracy of phenylalanyl-tRNA synthetase. A comparative study with enzymes from Escherichia coli, Saccharomyces cerevisiae, Neurospora crassa, and turkey liver using phenylalanine analogues.
    Gabius HJ; von der Haar F; Cramer F
    Biochemistry; 1983 May; 22(10):2331-9. PubMed ID: 6222761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic properties of pure overproduced Bacillus subtilis phenylalanyl-tRNA synthetase do not favour its in vivo inhibition by ochratoxin A.
    Roth A; Eriani G; Dirheimer G; Gangloff J
    FEBS Lett; 1993 Jul; 326(1-3):87-91. PubMed ID: 8325392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive enzyme-linked immunosorbent assay of ochratoxin A based on monoclonal antibodies.
    Kawamura O; Sato S; Kajii H; Nagayama S; Ohtani K; Chiba J; Ueno Y
    Toxicon; 1989; 27(8):887-97. PubMed ID: 2781587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in neurotoxic effects of ochratoxin A, ochracin and ochratoxin-alpha in vitro.
    Bruinink A; Rasonyi T; Sidler C
    Nat Toxins; 1998; 6(5):173-7. PubMed ID: 10398513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial position of aminoacylation of individual Escherichia coli, yeast, and calf liver transfer RNAs.
    Chinault AC; Tan KH; Hassur SM; Hecht SM
    Biochemistry; 1977 Feb; 16(4):766-76. PubMed ID: 319826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations induced in vitro by ochratoxin A in rat lymphoid cells.
    Alvarez-Erviti L; Leache C; González-Peñas E; de Cerain AL
    Hum Exp Toxicol; 2005 Sep; 24(9):459-66. PubMed ID: 16235735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain.
    Belmadani A; Tramu G; Betbeder AM; Steyn PS; Creppy EE
    Arch Toxicol; 1998 Oct; 72(10):656-62. PubMed ID: 9851682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrolytic action of aminoacyl-tRNA synthetases from baker's yeast: "chemical proofreading" preventing acylation of tRNA(I1e) with misactivated valine.
    von der Haar F; Cramer F
    Biochemistry; 1976 Sep; 15(18):4131-8. PubMed ID: 786367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats.
    Mally A; Pepe G; Ravoori S; Fiore M; Gupta RC; Dekant W; Mosesso P
    Chem Res Toxicol; 2005 Aug; 18(8):1253-61. PubMed ID: 16097798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.